Palisade Concentrated Equity Partnership II LP 13D/13G Filings for Brickell Biotech, Inc. (BBI)

Palisade Concentrated Equity Partnership II LP 13D and 13G filings for Brickell Biotech, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-09-24
3:47 pm
Purchase
2020-09-14 13D Brickell Biotech, Inc.
BBI
Palisade Concentrated Equity Partnership II LP 23,853
3.860%
1,336increase
(+5.94%)
Filing